Quality of life in patients with relapsing multiple sclerosis taking intramuscular interferon beta-1a (Avonex®)

被引：0
|
作者：
Hyde, R.
Rudick, R. A.
Foulds, P.
You, X.
机构：
[1] Biogen Idec Int, Zug, Switzerland
[2] Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH USA
[3] Biogen Idec Inc, Cambridge, MA 02142 USA
来源：
JOURNAL OF NEUROLOGY | 2008年 / 255卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P455
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [1] QUALITY OF LIFE IN RELAPSING REMMITING MULTIPLE SCLEROSIS: INFLUENCE OF INTERFERON BETA-1A (AVONEX AND CINNOVEX) TREATMENT
    Shahtaheri, R. S.
    Hatam, N.
    VALUE IN HEALTH, 2016, 19 (07) : A436 - A436
  • [2] Quality of life in 1000 patients with relapsing-remitting multiple sclerosis and the impact of treatment initiation with intramuscular interferon beta-1a
    Putzki, Norman
    Hartung, Hans Peter
    MULTIPLE SCLEROSIS, 2008, 14 : S149 - S149
  • [3] Interferon beta-1a (Avonex) increases cerebrospinal fluid interleukin-10 in patients with relapsing multiple sclerosis
    Rudick, RA
    Ransohoff, R
    Medendorp, S
    Boyle, S
    Peppler, R
    Jacobs, L
    Cockfair, D
    Herndon, R
    Richert, J
    Salazar, A
    Fischer, J
    Granger, C
    Simon, J
    Goodkin, D
    Wende, K
    ANNALS OF NEUROLOGY, 1996, 40 (03) : T244 - T244
  • [4] Cerebrospinal fluid abnormalities in a phase III trial interferon beta-1a (Avonex) for relapsing multiple sclerosis
    Rudick, RA
    Cookfair, RD
    Ransohoff, R
    Jacobs, L
    Herndon, R
    Richert, J
    Salazar, A
    Fischer, J
    Granger, C
    Simon, J
    Goodkin, D
    ANNALS OF NEUROLOGY, 1996, 40 (03) : M104 - M104
  • [5] Effects of statins on intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis
    Rudick, R.
    Pace, A.
    Panzara, M.
    Rani, S.
    Schrock, J.
    Calabresi, F.
    Confavreux, C.
    Galetta, S.
    Lublin, F.
    Radue, E. W.
    Stuart, W.
    Weinstock-Guttman, B.
    Wynn, D.
    MULTIPLE SCLEROSIS, 2007, 13 : S57 - S57
  • [6] Real-world outcomes in patients with relapsing forms of multiple sclerosis treated with intramuscular interferon beta-1a or peginterferon beta-1a
    Salter, A.
    Lancia, S.
    Cutter, G.
    Fox, R.
    Marrie, R. A.
    Avila, R.
    Vignos, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 187 - 187
  • [7] Efficacy and safety of interferon beta-1a for intramuscular injections biosimilar in patients with relapsing remitting multiple sclerosis
    Khabirov, F.
    Averianova, L.
    Babicheva, N.
    Dykhanov, A.
    Granatov, E.
    Khaybullin, T.
    Shakirzianova, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 446 - 447
  • [8] Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients
    Rudick, R. A.
    Kappos, L.
    Kinkel, R.
    Clanet, M.
    Phillips, J. T.
    Herndon, R. M.
    Sandrock, A. W.
    Munschauer, F. E., III
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (03) : 353 - 360
  • [9] Rebif - Interferon beta-1a - SERONO - Second interferon beta-1a product for relapsing multiple sclerosis
    不详
    FORMULARY, 2002, 37 (04) : 169 - 169
  • [10] Quality of life in low-disability multiple sclerosis patients participating in a phase III trial of interferon beta-1a for relapsing multiple sclerosis
    Cookfair, DL
    Fischer, J
    Rudick, R
    Bourdette, D
    OReilly, K
    Jacobs, L
    Herndon, R
    Richert, J
    Salazar, A
    Granger, C
    Simon, J
    Goodkin, D
    ANNALS OF NEUROLOGY, 1996, 40 (03) : T234 - T234
12345